MTS MEDICATION TECHNOLOGIES, INC /DE/

Q: Sep 30 2009

Q: Jun 30 2009

FY: Mar 31 2009

FY: Mar 31 2009

FY: Mar 31 2009

Q: Dec 31 2008

Q: Sep 30 2008

Q: Jun 30 2008

FY: Mar 31 2008

Q: Dec 31 2007

Q: Sep 30 2007

Q: Jun 30 2007

FY: Mar 31 2007

Q: Dec 31 2006

Q: Sep 30 2006

Q: Jun 30 2006

FY: Mar 31 2006

FY: Mar 31 2006

Q: Sep 30 2005

Q: Dec 31 2005

3.01,3.03,5.01,5.02,8.01,9.01

8.01,9.01

Results of Operations and Financial Condition

1.01,9.01

1.01,9.01

2.02,7.01,9.01

Results of Operations and Financial Condition

Results of Operations and Financial Condition

2.02,7.01,9.01

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

2.02,7.01,9.01

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

1.01,1.02,2.03,9.01

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

Results of Operations and Financial Condition

5.02,7.01,9.01

5.02

Notice of Effectiveness

Post Effective Amendment to S-8

Certification of termination of registration of a class of securities (Section 12(b))

Post-effective amendment to a registration statement

Notification of removal from listing and/or registration on a national securities exchange

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Registration of Securities on Exchange (amendment)

Post Effective Amendment to S-8

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Registration of Securities on Exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

No description available

No description available

No description available

No description available

Definitive Proxy Statement

No description available

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Conroy James Michael

MTS MEDICATION TECHNOLOGIES, INC /DE/

BORGIDA CHET

BRASWELL ALLEN S JR

CONROY MICHAEL P

Cohen Irv I

KAZARIAN DAVID W

Larson Perry W

Mercadante Edgardo A

SIEGEL TODD E

STANTON JOHN D

STEVENSON MICHAEL D

Williams Peter A

Radoff Bradley Louis

MTS MEDICATION TECHNOLOGIES, INC /DE/

MTS MEDICATION TECHNOLOGIES, INC /DE/

MTS MEDICATION TECHNOLOGIES, INC /DE/

MTS MEDICATION TECHNOLOGIES, INC /DE/

BURNHAM ASSET MANAGEMENT CORP /NY/

MTS MEDICATION TECHNOLOGIES, INC /DE/

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Notification of the removal from listing and registration of matured redeemed or retired securities

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available